Guillain-Barre Syndrome : Recent study

  • In a recent study from Israel, a connection was found between Covid-19 infection and a
    higher likelihood of being diagnosed with Guillain-Barre syndrome (GBS) within six
  • Guillain-Barre syndrome is a rare autoimmune disorder where the body’s immune
    system mistakenly attacks the peripheral nerves.
  • It Is more common in adults and males, but it can affect people of all ages.
  • The first symptoms of this syndrome include weakness or tingling sensations.
  • They usually start in the legs, and can spread to the arms and face.
  • For some people, these symptoms can lead to paralysis of the legs, arms, or muscles in
    the face.
  • It is often preceded by an infection.
  • This could be a bacterial or viral infection.
  • The most frequently associated infections include Campylobacter jejuni, Epstein-Barr
    virus (EBV), cytomegalovirus (CMV), and the bacteria responsible for pneumonia and
    urinary tract infections.
  • It may also be triggered by vaccine administration or surgery.
  • There is no known cure for this syndrome.
  • The most commonly used treatment is intravenous immunoglobulin (IVIG), which is
    made from donated blood that contains healthy antibodies.